Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis

Indian Journal of Medical Microbiology

Volumn 30, Issue 1, 2012, Pages 64-68

  Lazarus, R P ^a   Kalaiselvan, S ^a   John, K R ^a   Michael, J S ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

M. tuberculosis; MDR TB; microscopic observational drug susceptibility assay; tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; DIAGNOSTIC TEST; DOUBLE BLIND PROCEDURE; DRUG SENSITIVITY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MICROSCOPIC OBSERVATIONAL DRUG SUSCEPTIBILITY ASSAY; MULTIDRUG RESISTANT TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE;

EID: 84857871741     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.93039     Document Type: Article

References (12)

1. World Health Organization. Global tuberculosis control. WHO Report 2010. Geneva, Switzerland: WHO/CDS/TB/2010.275.
2. World Health Organization. Use of liquid TB culture and drug susceptibility testing (DST) in low-and middle-income countries. Summary report of the expert group meeting on the use of liquid culture media. Geneva, Switzerland: World Health Organization; 2007.
3. World Health Organization. WHO policy statement: Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis.Geneva,Switzerland:World Health Organization;2008.
4. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A,et al. MODS for the diagnosis of TB. N Engl J Med 2006;355:1539-50.
5. Arias M, Mello FC, Pavón A, Marsico AG, Alvarado-Gálvez C, Rosales S, et al. Clinical evaluation of the microscopicobservation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007;44:674-80.
6. Michael JS, Daley P, Kalaiselvan S, Latha A, Vijayakumar J, Mathai D, et al. Diagnostic accuracy of the microscopic observation drug susceptibility assay: A pilot study from India. Int J Tuberc Lung Dis 2010;14:482-8.
7. Microscopic Observation and Drug Susceptibility User Guide August 2008. Lima, Peru. MODS user guide v12.1 14082008.
8. Kent PT, Kubicka GP. Public Health Mycobacteriology: A guide for the Level III Laboratory. Atlanta, GA: Centers for Disease Control and Prevention; 1985.
9. Limaye K, Kanade S, Nataraj G, Mehta P.Utility of Microscopic Observation of Drug Susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J Tuberc 2010;57:207-12.
10. Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, et al. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Am J Respir Crit Care Med 2011;183:1427-33.
11. Dowdy DW, Chaisson RE, Moulton LH, Dorman SE. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: A mathematical model. AIDS 2006;20:751-62.
12. Anthony RM, Cobelens FG, Gebhard A, Klatser PR, Lumb R, Rüsch-Gerdes S, et al. Liquid culture for Mycobacterium tuberculosis: Proceed, but with caution. Int J Tuberc Lung Dis2009;13:1051-3.